Skip to Main Content

Author Details

Paul G Thomas
St. Jude Children's Research Hospital
2000
207
57
PMIDPaper TitleJournal TitlePublished Year
36596894NIAID workshop on T cell technologies.Nat Immunol2023
37749325Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan.Nat Immunol2023
37655660Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside.J Clin Invest2023
37503213Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2.bioRxiv2023
37533854Transcriptomic profiles of multiple organ dysfunction syndrome phenotypes in pediatric critical influenza.Front Immunol2023
37391405Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome.Nat Commun2023
36993205Integrated Drivers of Basal and Acute Immunity in Diverse Human Populations.bioRxiv2023
37248417Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.Nat Immunol2023
37030296Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.Cell Rep Med2023
37461683Establishing thresholds for cytokine storm and defining their relationship to disease severity in respiratory viral infections.bioRxiv2023
36851695How Estrogen, Testosterone, and Sex Differences Influence Serum Immunoglobulin Isotype Patterns in Mice and Humans.Viruses2023
36939421A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.J Immunol2023
34426704Integrating T cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA).Nat Biotechnol2022
35586986PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.mSphere2022
35841887Resolving SARS-CoV-2 CD4<sup>+</sup> T cell specificity via reverse epitope discovery.Cell Rep Med2022
35614224ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis.Nature2022
35545027Mucosal immune responses to infection and vaccination in the respiratory tract.Immunity2022
35792801Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages.Cancer Discov2022
35632569Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals.Vaccines (Basel)2022
35522615An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic.PLoS One2022
35589689SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.Nat Commun2022
35513723CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.Nat Genet2022
35446934Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.Blood Adv2022
36551771Microbiome Shapes the T Cell Receptor Repertoire among CD4+CD8+ Thymocytes.Biomedicines2022
36476997Comparing T cell receptor repertoires using optimal transport.PLoS Comput Biol2022
36109585Murine fetal bone marrow does not support functional hematopoietic stem and progenitor cells until birth.Nat Commun2022
36001673(E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins.Sci Adv2022
35970936VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2.Nat Methods2022
36206339Distinct roles of ORAI1 in T cell-mediated allergic airway inflammation and immunity to influenza A virus infection.Sci Adv2022
36302969PTEN directs developmental and metabolic signaling for innate-like T cell fate and tissue homeostasis.Nat Cell Biol2022
35986912DDX58 Is Associated With Susceptibility to Severe Influenza Virus Infection in Children and Adolescents.J Infect Dis2022
36087211Multimodal T Cell Analysis with CoNGA.Methods Mol Biol2022
35914226Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies.Blood2022
35074498PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8<sup>+</sup> T cells in breast cancer.Cancer Lett2022
35211640Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps.Mol Ther Methods Clin Dev2022
35119937Antigen cross-presentation in young tumor-bearing hosts promotes CD8<sup>+</sup> T cell terminal differentiation.Sci Immunol2022
34965382Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.Cell Host Microbe2022
35263574Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.Cell Rep2022
35105983Immunology of SARS-CoV-2 infection in children.Nat Immunol2022
32881995Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.Blood2021
33824495Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract.Nat Rev Microbiol2021
33579926Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.Nat Commun2021
34557558Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy.Open Forum Infect Dis2021
34704832An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.Microbiol Spectr2021
34788094Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.Sci Adv2021
34462740Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity.Res Sq2021
34578367Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses.Viruses2021
34845983TCR meta-clonotypes for biomarker discovery with <i>tcrdist3</i> enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs.Elife2021
34845450Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery.bioRxiv2021
34301764Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.Cancer Res2021
  • 1 - 50 of 207

Recommended Authors

Tianyang Mao
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Alexandra Tsitsiklis
University of California san francisco
Career Start Year 2016
Number of shared co-authors 4
Patrick Wong
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Carolina Lucas
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 5
Peiwen Lu
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 7
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 38
Jacob D Eccles
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 0
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 9
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 13
Franklin R Toapanta
University of Maryland School of Medicine
Career Start Year 2004
Number of shared co-authors 3
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 15
Bjoern Peters
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 11
Subhasis Mohanty
Yale School of Medicine, Yale University
Career Start Year 2002
Number of shared co-authors 1
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 2
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 1
Michelle A Gill
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 4
Cristina M Tato
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 2
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 9
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 9
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 3
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
Albert C Shaw
Yale School of Medicine, Yale University
Career Start Year 1987
Number of shared co-authors 2
Gregory A Poland
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 3
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 12
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 15
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 14

Collaborators

Pradyot Dash
St. Jude Children's Research Hospital
Co-authored papers 26
Adrienne G Randolph
Boston Children's Hospital, Harvard Medical School
Co-authored papers 7
Catherine J Sanders
St. Jude Children's Research Hospital
Co-authored papers 7
Geoffrey Neale
St. Jude Children's Research Hospital
Co-authored papers 6
Haley A Brown
Co-authored papers 5
Carrie M Rosenberger
Genentech Inc.
Co-authored papers 5
Alan Aderem
Seattle Children's Research Institute
Co-authored papers 4
Aditya H Gaur
St. Jude Children's Research Hospital
Co-authored papers 4
Anthony W Purcell
Monash Biomedicine Discovery Institute, Monash University
Co-authored papers 4
Garnet Navarro
Universidad Antonio Narino
Co-authored papers 3
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 3
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Peter S Askovich
Center for Infectious Disease Research
Co-authored papers 3
Vincent C Tam
Temple University
Co-authored papers 3
Alan H Diercks
Seattle Children's Research Institute
Co-authored papers 3
Mark W Hall
Nationwide Children's Hospital, The Ohio State University
Co-authored papers 3
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 3
Natalie Z Cvijanovich
UCSF Benioff Children's Hospital Oakland
Co-authored papers 3
Barry P Markovitz
Children's Hospital Los Angeles
Co-authored papers 2
Christoph Lange
Co-authored papers 2
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 2
Gary P Kobinger
University of Texas Medical Branch
Co-authored papers 2
Adam J Schwarz
Children's Hospital of Orange County
Co-authored papers 2
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Co-authored papers 2
Carl F Ware
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Tushar Bhangale
Genentech Inc.
Co-authored papers 2
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Nancy J Cox
Vanderbilt University Medical Center
Co-authored papers 2
Andrew Pekosz
Co-authored papers 2
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 2
Release 1.2